Medline Inc.
MDLN
$38.55
-$0.70-1.78%
NASDAQ
| 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | -48.47% | -31.17% | -- | -- | -- |
| Total Depreciation and Amortization | -22.11% | -22.11% | -- | -- | -- |
| Total Amortization of Deferred Charges | -31.62% | -22.81% | -- | -- | -- |
| Total Other Non-Cash Items | 7.13% | -8.57% | -- | -- | -- |
| Change in Net Operating Assets | 31.10% | 59.11% | -- | -- | -- |
| Cash from Operations | -32.47% | -12.55% | -- | -- | -- |
| Capital Expenditure | 11.61% | 7.42% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 100.53% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 75.83% | 77.83% | -- | -- | -- |
| Total Debt Issued | -39.26% | -51.87% | -- | -- | -- |
| Total Debt Repaid | 8.49% | 26.63% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -9,366.67% | -9,885.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 85.27% | 85.84% | -- | -- | -- |
| Other Financing Activities | -13.04% | -- | -- | -- | -- |
| Cash from Financing | 140.36% | 145.07% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -237.50% | 150.00% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 229.37% | 245.92% | -- | -- | -- |